🇺🇸 FDA
Pipeline program

ropivacaine

Dex

Approved small_molecule completed

Quick answer

ropivacaine for Injury of Upper Limb is a Approved program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Injury of Upper Limb
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials